CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 60 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $9,965 | +18.6% | 11,106 | 0.0% | 0.00% | – |
| Q4 2023 | $8,402 | +10.5% | 11,106 | 0.0% | 0.00% | – |
| Q3 2023 | $7,601 | -43.0% | 11,106 | 0.0% | 0.00% | – |
| Q2 2023 | $13,327 | +2.6% | 11,106 | 0.0% | 0.00% | – |
| Q1 2023 | $12,994 | +48.1% | 11,106 | 0.0% | 0.00% | – |
| Q4 2022 | $8,774 | -32.5% | 11,106 | 0.0% | 0.00% | – |
| Q3 2022 | $13,000 | – | 11,106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 498,783 | $394 | 0.05% |
| Inspire Advisors, LLC | 195,946 | $154,797 | 0.04% |
| Wealth Advisory Solutions, LLC | 155,850 | $123,122 | 0.03% |
| Miller Investment Management, LP | 50,000 | $39,500 | 0.01% |
| Virtu Financial LLC | 39,005 | $31 | 0.00% |
| Pasadena Private Wealth, LLC | 10,965 | $8,662 | 0.00% |
| Jump Financial, LLC | 49,251 | $38,908 | 0.00% |
| Qube Research & Technologies Ltd | 120,580 | $95,258 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 61,613 | $48,674 | 0.00% |
| Kestra Advisory Services, LLC | 93,717 | $74,036 | 0.00% |